Published in Cancer Weekly, May 25th, 1998
Marking its emergence, the first supplement to the journal Nature Medicine is dedicated to vaccinology. The issue, which carries no advertising, is sponsored by the Merck Vaccine Division.
"Why vaccines'" rhetorically asks Nature Medicine editor Adrian J. Ivinson in an opening editorial. His answer is twofold: that there has been "a spate of vaccine research activity" based on "a better mechanistic underpinning to vaccine design;" and that there is growing government and public awareness of vaccine importance.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.